InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: couldbebetter post# 387348

Friday, 08/26/2022 9:50:22 AM

Friday, August 26, 2022 9:50:22 AM

Post# of 426487
CBB...IMO China is a key for Vascepa...China approval,which is scheduled to come this year, will lead to...
1. low prices in China
2. lower prices in the U.S., Europe, and ROW
3. acceptance globally
4. emergence of Vascepa as a volume play
5. large cash flow
6. investments on alternative methods of producing EPA
7. investments in additional indications for Vascepa
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News